NEW YORK (GenomeWeb News) – Biotage is shifting to publicly traded common shares that will trade under the new ticker symbol BIOT, the Swedish company said today.
 
Only common shares will be available for Biotage investors after March 29, when it changes out its A-shares to Ak securities without serial identification, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.